RMIT University researchers have developed a new way to coat fragile surfaces, including living plant leaves, using ...

There are all manner of musical synthesis techniques, from the early electromechanical instruments through analogue tape ...

Rohde & Schwarz recently announced the MXO3, a 1 GHz, 12-bit oscilloscope. The company sent a review unit. In this part, I found that it has some nice features for making EMC measurements, though it ...

SunZia has quietly begun sending enormous amounts of wind power to California, as President Donald Trump works to thwart the wind industry. The largest renewable energy project ever built in the ...

Star Wars producer Kathleen Kennedy was one of the few skeptics at the Runway AI Summit, where AI was compared to fire and the printing press just a week after Sora’s death. As Kennedy told an ...

Alarm clocks ring at early hours around the country for those in the sandwich generation. In Hercules, a town 25 miles northeast of San Francisco, Nicole Cabuloy Torres’ alarm clock buzzes at 4:30 a.m ...

Primary Wave Music has announced a “definitive” agreement to acquire Kobalt, one of the world’s largest independent music publishing and technology platforms, from Francisco Partners, creating a ...

Jackie Allen, Jr., a third-generation farmer in Bardstown, Kentucky, leases two hundred and sixty acres near the Beech Fork River, and accepts that the family business ends with him. His progeny ...

The Federal Reserve's pause on rate cuts means investors can still grab attractive yields on short-duration assets. The central bank opted to keep the federal funds rate between 3.5% to 3.75% on ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...